Spatiotemporal characterization of disease-associated neurons in the entorhinal cortex-hippocampal circuit during Alzheimer’s disease progression
Open Access
- 10 June 2025
- journal article
- Published by Oxford University Press (OUP) in Protein & Cell
Abstract
The entorhinal cortex (EC)-hippocampal (HPC) circuit is particularly vulnerable to Alzheimer’s disease (AD) pathology, yet the underlying molecular mechanisms remain unclear. By employing the high-depth sequencing strategy Smart-seq2, we tracked gene expression changes across various neuron types within this circuit at different stages of AD pathology. We observed a decrease in the extent of gene expression changes in AD versus wild-type (WT) mice as the disease advanced. Functionally, we demonstrate that both mitochondrial and ribosomal pathways were increasingly activated, while neuronal pathways were inhibited with AD progression. Our findings indicate that the reduction of EC-stellate cells disrupts Meg3-mediated energy metabolism, contributing to energy dysfunction in AD. Additionally, we identified GFAP-positive neurons as a distinct population of disease-associated neurons, exhibiting a loss of neuronal-like characteristics, alongside the emergence of glia- and stem-like features. The number of GFAP-positive neurons increased with AD progression, a trend consistently observed in both AD model mice and AD patients. In summary, this study identifies and characterizes GFAP-positive neurons as a novel subtype of disease-associated neurons in AD pathology, providing insights into their potential role in disease progression.Keywords
Funding Information
- National Natural Science Foundation of China (82125009, 82330045, 32121002, 82071185, 82172061, 92149303)
- National Key Research and Development Program of China (2020YFA0509300, 2021YFA0804900, 2022YFC2703102)
- Strategic Priority Research Program of the Chinese Academy of Sciences (XDB39000000)
- Young Scientists in Basic Research (YSBR-013)
- Major Provincial Science & Technology Projects (202303a07020004)
- National Science Center Hefei Brain Project
- Center for Advanced Interdisciplinary Science and Biomedicine of IHM (QYZD20220003)
- Major Frontier Research Project of the University of Science and Technology of China (LS9100000002)
- S&T Program of Shijiazhuang (235790429H)
This publication has 53 references indexed in Scilit:
- Astroglial activation: Current concepts and future directionsAlzheimer's & Dementia, 2024
- Differences Between Plasma and Cerebrospinal Fluid Glial Fibrillary Acidic Protein Levels Across the Alzheimer Disease ContinuumJAMA Neurology, 2021
- A taxonomy of transcriptomic cell types across the isocortex and hippocampal formationCell, 2021
- Spatial Transcriptomics and In Situ Sequencing to Study Alzheimer’s DiseaseCell, 2020
- Neurons and networks in the entorhinal cortex: A reappraisal of the lateral and medial entorhinal subdivisions mediating parallel cortical pathwaysHippocampus, 2019
- Upregulation of the lncRNA MEG3 improves cognitive impairment, alleviates neuronal damage, and inhibits activation of astrocytes in hippocampus tissues in Alzheimer's disease through inactivating the PI3K/Akt signaling pathwayJournal of Cellular Biochemistry, 2019
- Quiescence Modulates Stem Cell Maintenance and Regenerative Capacity in the Aging BrainCell, 2019
- A Unique Microglia Type Associated with Restricting Development of Alzheimer’s DiseaseCell, 2017
- Brain Energy Metabolism: Focus on Astrocyte-Neuron Metabolic CooperationCell Metabolism, 2011
- Neurofibrillary changes confined to the entorhinal region and an abundance of cortical amyloid in cases of presenile and senile dementiaActa Neuropathologica, 1990